alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › passive

passive

4 studies tagged passive, dated 2013-05-11 to 2026-07-16. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Passive amyloid-β immunotherapy in Alzheimer's disease: a multicellular clearance system beyond plaque removal 2026-07-16
  2. Assessment of Social Behavior Using a Passive Monitoring App in Cognitively Normal and Cognitively Impaired Older Adults: Observational Study 2022-05-20
  3. Passive antiamyloid immunotherapy for Alzheimer's disease 2020-05-01

Studies

4 studies carry this tag.

Date range

2013 to 2026

Top journals

  • Current opinion in psychiatry 1
  • Immunity & ageing : I & A 1
  • JMIR aging 1
  • Molecular neurodegeneration 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Passive amyloid-β immunotherapy in Alzheimer's disease: a multicellular clearance system beyond plaque removal

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Molecular neurodegeneration 2026-07-16 Treatments

    Passive immunotherapy targeting amyloid-β (Aβ) has emerged as a major therapeutic strategy for Alzheimer's disease (AD), yet its clinical benefits remain modest and are frequently accompanied by vascular adverse events such as amyloid-related imaging abnormalities (ARIA).

  2. Assessment of Social Behavior Using a Passive Monitoring App in Cognitively Normal and Cognitively Impaired Older Adults: Observational Study

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. JMIR aging 2022-05-20 Cognitive tests and assessment

    CI individuals show reduced social activity, especially those activities that are related to repeated and unique behavior, as measured by the smartphone app Behapp.

  3. Passive antiamyloid immunotherapy for Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Current opinion in psychiatry 2020-05-01 Treatments

    Antiamyloid therapy of Alzheimer's disease tackles the overproduction and clearance of the amyloid-beta peptide (Aβ).

  4. Passive anti-amyloid immunotherapy in Alzheimer's disease: What are the most promising targets?

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Immunity & ageing : I & A 2013-05-11 Treatments

    Alzheimer's disease (AD) is the most common dementia in the industrialized world, with prevalence rates well over 30% in the over 80-years-old population.

All topic tags with their study counts